• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    Eisai’s Biologics Leqembi Receives Approval in US

    FDA

    Eisai`s Biologic Leqembi Receives Suppl Approval in US

    FDA

    Eisai`s Biologic Leqembi (lecanemab-irmb) Receives Approval in U.S.

    FDA

    Eisai`s Ontak (Denileukin Diftitox) Receives Supplemental Approval in US

    FDA

    Eisai`s Entak (Denileukin Diftitox) Receives Approval in US

    FDA

    Eisai`s Kisplyx (lenvatinib mesilate) Receives Approval for Europe

    EMA

    Eisai Inc. & Arena Announce FDA Approval Of BELVIQ XR (Lorcaserin Hcl)

    FDA

    EISAI`s Fycompa (Perampanel) approved in US for Epilepsy

    FDA

    Eisai`s Lenvima (Lenvatinib Mesylate) Approved in Europe For Thyroid Neoplasms

    EMA

    Eisai`s Fycompa (Perampanel) Receives Supplemental Approval in US For Seizures

    FDA

    Eisai’s Lenvima (Lenvatinib) Approved In Europe For Thyroid Carcinoma

    EMA

    Eisai`s LENVIMA (Lenvatinib Mesylate) Approved in USA for Thyroid Cancer

    EISAI

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.